Advances in the Molecular Pathogenesis of T-cell Lymphoma
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Pathophysiology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 57
Special Issue Editor
Special Issue Information
Dear Colleagues,
With the recent advent of high-throughput technologies, there have been many advances in our understanding of the molecular pathogenesis of T-cell lymphoma. The parallel classification of T-cell lymphoma has been further refined, and novel prognostic and theranostic biomarkers have been identified. The purpose of this Special Issue is to highlight recent advances in the molecular pathogenesis of T-cell lymphomas. Original research articles and comprehensive reviews are welcome.
Dr. Richard Flavin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pathogenesis
- molecular biology
- T-cell neoplasia/lymphoma
- biomarkers
